Related Experiment Video

Updated: Jun 5, 2026

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

Comment on: isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from

Claudio U Köser, David K Summers, John A C Archer

    The Journal of Antimicrobial Chemotherapy
    |December 24, 2010
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
    08:10

    Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

    Published on: April 9, 2012

    Related Experiment Videos

    Last Updated: Jun 5, 2026

    Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
    07:35

    Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

    Published on: April 25, 2014

    Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
    08:10

    Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

    Published on: April 9, 2012

    Related Concept Videos

    Pulmonary Tuberculosis V01:28

    Pulmonary Tuberculosis V

    Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
    Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

    Articles linked to this work by shared authors, journal, and citation graph.

    Implications of edge cases for antimicrobial susceptibility predictions for rifampin, delamanid, and pretomanid with the WHO Mycobacterium tuberculosis mutation catalog.

    Microbiology spectrum·2026

    The role of whole genome sequencing in antimicrobial susceptibility prediction of bacteria: 2025 update from the European Committee on Antimicrobial Susceptibility Testing Subcommittee.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026

    In vitro exposure to clofazimine can select for delamanid and pretomanid resistance in Mycobacterium tuberculosis.

    Antimicrobial agents and chemotherapy·2025

    The ahpC c-54t compensatory mutation is not always a valid surrogate for isoniazid resistance in Mycobacterium tuberculosis.

    Antimicrobial agents and chemotherapy·2025

    The exceptions that prove the rule-a historical view of bedaquiline susceptibility.

    Genome medicine·2024

    Refined understanding of the impact of the Mycobacterium tuberculosis complex diversity on the intrinsic susceptibility to pretomanid.

    Microbiology spectrum·2024

    Cefoxitin versus cefotaxime as empirical treatment of spontaneous bacterial peritonitis in liver cirrhotic patients: randomized controlled clinical trial.

    The Journal of antimicrobial chemotherapy·2026

    BV100 (rifabutin IV) drug interaction studies in healthy subjects with index CYP450 3A probes midazolam and itraconazole.

    The Journal of antimicrobial chemotherapy·2026

    Systematic screening identified broad-spectrum inhibitors of human-pathogenic Encephalitozoon species and revealed no in vitro activity of nitazoxanide.

    The Journal of antimicrobial chemotherapy·2026

    HIV-1 integrase inhibitor resistance in viraemic-treated individuals and baseline capsid diversity relevant to future lenacapavir therapy.

    The Journal of antimicrobial chemotherapy·2026

    Reconciling differences between EUCAST 'breakpoint-defining doses' and UK national antimicrobial treatment guidelines.

    The Journal of antimicrobial chemotherapy·2026

    Efficacy of new antimicrobial agents against carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant Enterobacterales in Japan: national genomic surveillance (JARBS 2.0) study.

    The Journal of antimicrobial chemotherapy·2026

    Efficacy of quabodepistat alone and in combination with delamanid and bedaquiline against Mycobacterium tuberculosis in an NHP model evaluated by [18F] FDG PET/CT and bacterial burden.

    Antimicrobial agents and chemotherapy·2026

    From Clean to Colonized: Microbial Dynamics of Bed Linen Over Time.

    Letters in applied microbiology·2026

    Redesigning Microbiology Order Architecture to Improve Laboratory Efficiency.

    The journal of applied laboratory medicine·2026

    Clinical Outcomes and In Vitro Growth Inhibition of Severe Fungal Keratitis Treated With Adjunct Rose Bengal Photodynamic Therapy (RB PDT).

    Cornea·2026

    Early antibiotic review and AWaRe prescribing in respiratory infections before vs during COVID-19: a two-hospital retrospective cohort study.

    Journal of pharmaceutical policy and practice·2026

    Study on Baicalin Treatment of Mycoplasma pneumoniae Based on D1/ART/LTB4R Pathway.

    Drug design, development and therapy·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us